NCT00445900View on ClinicalTrials.gov

Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Chronic Myeloproliferative DisordersSecondary Myelofibrosis
Interventions
DRUG

cyclophosphamide

DRUG

prednisone

DRUG

thalidomide

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

PROCEDURE

biopsy

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER